Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

The way forward for ETEC controlled human infection models (CHIMs).

Hanevik K, Chen WH, Talaat KR, Porter C, Bourgeois L.

Vaccine. 2019 Aug 7;37(34):4794-4799. doi: 10.1016/j.vaccine.2019.01.003. Epub 2019 Jan 29.

2.

Enterotoxigenic E. coli virulence gene regulation in human infections.

Crofts AA, Giovanetti SM, Rubin EJ, Poly FM, Gutiérrez RL, Talaat KR, Porter CK, Riddle MS, DeNearing B, Brubaker J, Maciel M Jr, Alcala AN, Chakraborty S, Prouty MG, Savarino SJ, Davies BW, Trent MS.

Proc Natl Acad Sci U S A. 2018 Sep 18;115(38):E8968-E8976. doi: 10.1073/pnas.1808982115. Epub 2018 Aug 20.

3.

Campylobacter jejuni transcriptional and genetic adaptation during human infection.

Crofts AA, Poly FM, Ewing CP, Kuroiwa JM, Rimmer JE, Harro C, Sack D, Talaat KR, Porter CK, Gutierrez RL, DeNearing B, Brubaker J, Laird RM, Maue AC, Jaep K, Alcala A, Tribble DR, Riddle MS, Ramakrishnan A, McCoy AJ, Davies BW, Guerry P, Trent MS.

Nat Microbiol. 2018 Apr;3(4):494-502. doi: 10.1038/s41564-018-0133-7. Epub 2018 Mar 27.

4.

Intranasal Live Influenza Vaccine Priming Elicits Localized B Cell Responses in Mediastinal Lymph Nodes.

Jegaskanda S, Mason RD, Andrews SF, Wheatley AK, Zhang R, Reynoso GV, Ambrozak DR, Santos CP, Luke CJ, Matsuoka Y, Brenchley JM, Hickman HD, Talaat KR, Permar SR, Liao HX, Yewdell JW, Koup RA, Roederer M, McDermott AB, Subbarao K.

J Virol. 2018 Apr 13;92(9). pii: e01970-17. doi: 10.1128/JVI.01970-17. Print 2018 May 1.

5.

Rifaximin Fails to Prevent Campylobacteriosis in the Human Challenge Model: A Randomized, Double-Blind, Placebo-Controlled Trial.

Rimmer JE, Harro C, Sack DA, Talaat KR, Gutierrez RL, DeNearing B, Brubaker J, Laird RM, Poly F, Maue AC, Jaep K, Alcala A, Mochalova Y, Gariepy CL, Chakraborty S, Guerry P, Tribble DR, Porter CK, Riddle MS.

Clin Infect Dis. 2018 Apr 17;66(9):1435-1441. doi: 10.1093/cid/cix1014.

PMID:
29145631
6.

Rapid changes in serum cytokines and chemokines in response to inactivated influenza vaccination.

Talaat KR, Halsey NA, Cox AB, Coles CL, Durbin AP, Ramakrishnan A, Bream JH.

Influenza Other Respir Viruses. 2018 Mar;12(2):202-210. doi: 10.1111/irv.12509. Epub 2018 Jan 4.

7.

Mycobacteria induce TPL-2 mediated IL-10 in IL-4-generated alternatively activated macrophages.

Chatterjee S, Talaat KR, van Seventer EE, Feng CG, Scott AL, Jedlicka A, Dziedzic A, Nutman TB.

PLoS One. 2017 Jun 28;12(6):e0179701. doi: 10.1371/journal.pone.0179701. eCollection 2017.

8.

Safety and Immunogenicity of Pfs25-EPA/Alhydrogel®, a Transmission Blocking Vaccine against Plasmodium falciparum: An Open Label Study in Malaria Naïve Adults.

Talaat KR, Ellis RD, Hurd J, Hentrich A, Gabriel E, Hynes NA, Rausch KM, Zhu D, Muratova O, Herrera R, Anderson C, Jones D, Aebig J, Brockley S, MacDonald NJ, Wang X, Fay MP, Healy SA, Durbin AP, Narum DL, Wu Y, Duffy PE.

PLoS One. 2016 Oct 17;11(10):e0163144. doi: 10.1371/journal.pone.0163144. eCollection 2016.

9.

The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model.

Kirkpatrick BD, Whitehead SS, Pierce KK, Tibery CM, Grier PL, Hynes NA, Larsson CJ, Sabundayo BP, Talaat KR, Janiak A, Carmolli MP, Luke CJ, Diehl SA, Durbin AP.

Sci Transl Med. 2016 Mar 16;8(330):330ra36. doi: 10.1126/scitranslmed.aaf1517. Epub 2016 Mar 16.

PMID:
27089205
10.

The safety of influenza vaccines in children: An Institute for Vaccine Safety white paper.

Halsey NA, Talaat KR, Greenbaum A, Mensah E, Dudley MZ, Proveaux T, Salmon DA.

Vaccine. 2015 Dec 30;33 Suppl 5:F1-F67. doi: 10.1016/j.vaccine.2015.10.080. Review.

11.

Treatment of W. bancrofti (Wb) in HIV/Wb coinfections in South India.

Talaat KR, Babu S, Menon P, Kumarasamy N, Sharma J, Arumugam J, Dhakshinamurthy K, Srinivasan R, Poongulali S, Gu W, Fay MP, Swaminathan S, Nutman TB.

PLoS Negl Trop Dis. 2015 Mar 20;9(3):e0003622. doi: 10.1371/journal.pntd.0003622. eCollection 2015 Mar.

12.

Development of live attenuated influenza vaccines against pandemic influenza strains.

Coelingh KL, Luke CJ, Jin H, Talaat KR.

Expert Rev Vaccines. 2014 Jul;13(7):855-71. doi: 10.1586/14760584.2014.922417. Epub 2014 May 28. Review.

PMID:
24867587
13.

A live attenuated influenza A(H5N1) vaccine induces long-term immunity in the absence of a primary antibody response.

Talaat KR, Luke CJ, Khurana S, Manischewitz J, King LR, McMahon BA, Karron RA, Lewis KD, Qin J, Follmann DA, Golding H, Neuzil KM, Subbarao K.

J Infect Dis. 2014 Jun 15;209(12):1860-9. doi: 10.1093/infdis/jiu123. Epub 2014 Mar 5. Erratum in: J Infect Dis. 2014 Dec 15;210(12):2021.

14.

Experimental infection of adults with recombinant wild-type human metapneumovirus.

Talaat KR, Karron RA, Thumar B, McMahon BA, Schmidt AC, Collins PL, Buchholz UJ.

J Infect Dis. 2013 Nov 15;208(10):1669-78. doi: 10.1093/infdis/jit356. Epub 2013 Aug 1.

15.

A single dose of any of four different live attenuated tetravalent dengue vaccines is safe and immunogenic in flavivirus-naive adults: a randomized, double-blind clinical trial.

Durbin AP, Kirkpatrick BD, Pierce KK, Elwood D, Larsson CJ, Lindow JC, Tibery C, Sabundayo BP, Shaffer D, Talaat KR, Hynes NA, Wanionek K, Carmolli MP, Luke CJ, Murphy BR, Subbarao K, Whitehead SS.

J Infect Dis. 2013 Mar 15;207(6):957-65. doi: 10.1093/infdis/jis936. Epub 2013 Jan 17.

16.

An open-label phase I trial of a live attenuated H2N2 influenza virus vaccine in healthy adults.

Talaat KR, Karron RA, Liang PH, McMahon BA, Luke CJ, Thumar B, Chen GL, Min JY, Lamirande EW, Jin H, Coelingh KL, Kemble GW, Subbarao K.

Influenza Other Respir Viruses. 2013 Jan;7(1):66-73. doi: 10.1111/j.1750-2659.2012.00350.x. Epub 2012 Mar 14.

17.

Immune response following H1N1pdm09 vaccination: differences in antibody repertoire and avidity in young adults and elderly populations stratified by age and gender.

Khurana S, Verma N, Talaat KR, Karron RA, Golding H.

J Infect Dis. 2012 Feb 15;205(4):610-20. doi: 10.1093/infdis/jir791. Epub 2011 Dec 29.

PMID:
22207649
18.

An open label Phase I trial of a live attenuated H6N1 influenza virus vaccine in healthy adults.

Talaat KR, Karron RA, Luke CJ, Thumar B, McMahon BA, Chen GL, Lamirande EW, Jin H, Coelingh KL, Kemble G, Subbarao K.

Vaccine. 2011 Apr 12;29(17):3144-8. doi: 10.1016/j.vaccine.2011.02.043. Epub 2011 Mar 4.

19.

A species-specific approach to the use of non-antimony treatments for cutaneous leishmaniasis.

Ramanathan R, Talaat KR, Fedorko DP, Mahanty S, Nash TE.

Am J Trop Med Hyg. 2011 Jan;84(1):109-17. doi: 10.4269/ajtmh.2011.10-0437.

20.

A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults.

Talaat KR, Greenberg ME, Lai MH, Hartel GF, Wichems CH, Rockman S, Jeanfreau RJ, Ghosh MR, Kabongo ML, Gittleson C, Karron RA.

J Infect Dis. 2010 Nov 1;202(9):1327-37. doi: 10.1086/656601.

PMID:
20874515
21.

Lymphocytic vasculitis involving the central nervous system occurs in patients with X-linked lymphoproliferative disease in the absence of Epstein-Barr virus infection.

Talaat KR, Rothman JA, Cohen JI, Santi M, Choi JK, Guzman M, Zimmerman R, Nallasamy S, Brucker A, Quezado M, Pittaluga S, Patronas NJ, Klion AD, Nichols KE.

Pediatr Blood Cancer. 2009 Dec;53(6):1120-3. doi: 10.1002/pbc.22185.

22.

A live attenuated H7N3 influenza virus vaccine is well tolerated and immunogenic in a Phase I trial in healthy adults.

Talaat KR, Karron RA, Callahan KA, Luke CJ, DiLorenzo SC, Chen GL, Lamirande EW, Jin H, Coelingh KL, Murphy BR, Kemble G, Subbarao K.

Vaccine. 2009 Jun 8;27(28):3744-53. doi: 10.1016/j.vaccine.2009.03.082. Epub 2009 Apr 17.

23.

Filarial/human immunodeficiency virus coinfection in urban southern India.

Talaat KR, Kumarasamy N, Swaminathan S, Gopinath R, Nutman TB.

Am J Trop Med Hyg. 2008 Oct;79(4):558-60.

24.

Methotrexate as a corticosteroid-sparing agent in complicated neurocysticercosis.

Mitre E, Talaat KR, Sperling MR, Nash TE.

Clin Infect Dis. 2007 Feb 15;44(4):549-53. Epub 2007 Jan 8.

PMID:
17243058
25.

Preexposure to live Brugia malayi microfilariae alters the innate response of human dendritic cells to Mycobacterium tuberculosis.

Talaat KR, Bonawitz RE, Domenech P, Nutman TB.

J Infect Dis. 2006 Jan 15;193(2):196-204. Epub 2005 Dec 13.

PMID:
16362883

Supplemental Content

Loading ...
Support Center